Non-Hodgkin’s Lymphomas, Version 1.2013

Restricted access

These NCCN Guidelines Insights summarize several key updates to the NCCN Guidelines for Non-Hodgkin’s Lymphomas (NHL) and provide a discussion of the clinical evidence that support the updates. The updates discussed in this article feature recommendations for additional treatment options in patients with chronic lymphocytic leukemia and guidance surrounding the management of hepatitis virus reactivation/infections in high-risk patients with NHL undergoing antitumor therapy.

Supplementary Materials

    • Supplemental Material (PDF 921 KB)
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 232 232 25
PDF Downloads 29 29 2
EPUB Downloads 0 0 0